BURLESON RESEARCH TECHNOLOGIES, INC. - IGF::CL::IGF R&D STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY
Key Details
Description
IGF::CL::IGF R&D STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY
Context & Analysis
On Feb 12, 2026, Department of Health and Human Services obligated $30,219,569.75 to BURLESON RESEARCH TECHNOLOGIES, INC. for igf::cl::igf r&d studies to evaluate the potential for environmental&therapeutic agents to induce immunotoxicity. The award is classified under NAICS 541712 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition with 4 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in MORRISVILLE, NC. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541712 — related awards are listed below.
Contractor Information
Similar Awards
IGF::OT::IGF CHEMISTRY SERVICES FOR THE NATIONAL TOXICOLOGY PROGRAM
RESEARCH TRIANGLE INSTITUTE
$54.3M
IGF::OT::IGF CHEMISTRY SERVICES FOR THE NATIONAL TOXICOLOGY PROGRAM
RESEARCH TRIANGLE INSTITUTE
$54.3M
IGF::OT::IGF CHEMISTRY SERVICES FOR THE NTP
MRIGLOBAL
$50.9M
IGF::CL::IGF WOMEN'S HEALTH INITIATIVE - CLINICAL COORDINATING CENTER
FRED HUTCHINSON CANCER RESEARCH CENTER
$49.7M
IGF::OT::IGFCHEMISTRY SERVICES FOR THE NTP
BATTELLE MEMORIAL INSTITUTE
$43.2M
Stay Updated
Get notified about new opportunities matching your interests.